Related Experiment Video
Updated: Jun 8, 2026

09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
How do tumors actively escape from host immunosurveillance?
Jacek R Wilczyński1, Markus Duechler
1Department of Gynecology, Medical University of Lodz, Kosciuszki 4, 90-419 Lodz, Poland. jrwil@post.pl
Archivum Immunologiae Et Therapiae Experimentalis
|October 6, 2010
Summary
Tumor growth is poorly understood, but cancer immunotherapy may benefit from knowing how tumors evade immune detection. Tumors can grow by hiding from or actively disrupting immune responses.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- The precise immunological mechanisms driving tumor growth remain largely unknown.
- Understanding tumor-immune interactions is crucial for advancing cancer immunotherapy.
- Tumor progression relies on either immune tolerance or active evasion of immunosurveillance.
Purpose of the Study:
- To elucidate the immunological basis of tumor growth.
- To explore the mechanisms by which tumors escape host immunosurveillance.
- To identify how immune responses are modulated within the tumor microenvironment.
Main Methods:
- Review and synthesis of existing studies on tumor immunology and immunoregulation.
- Analysis of mechanisms involved in tumor recognition and destruction.
- Investigation of tumor escape strategies.
Main Results:
- Tumor growth is facilitated by the tumor's ability to avoid recognition or actively subvert immune responses.
- Key evasion mechanisms include altered tumor immunogenicity, production of regulatory molecules, and interactions with tumor-infiltrating immune cells.
- Evidence supports the 'tumor escape' hypothesis as a primary driver of tumor progression.
Conclusions:
- The 'tumor escape' hypothesis provides a framework for understanding tumor growth.
- Targeting tumor evasion mechanisms holds promise for novel cancer immunotherapy strategies.
- Further research into tumor immunoregulation is essential for clinical applications.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell-mediated Immune Responses
Overview

